Lineage Cell Therapeutics (LCTX) Gross Margin Growth (3y) (2014 - 2026)
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Gross Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 14,836.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 589.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 53.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 569.00 |
| 10 | Lineage Cell Therapeutics | 270.71 Mn | 213.99 Mn | 1.07 Mn | 394.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 394.00 |
| Mar 31, 2026 | 499.00 |
| Dec 31, 2025 | 433.00 |
| Sep 30, 2025 | 770.00 |
| Jun 30, 2025 | 331.00 |
| Mar 31, 2025 | 96.00 |
| Dec 31, 2024 | 9,270.00 |
| Sep 30, 2024 | 4,239.00 |
| Jun 30, 2024 | 2,129.00 |
| Mar 31, 2024 | 2,186.00 |
| Dec 31, 2023 | 1,985.00 |
| Sep 30, 2023 | 430.00 |
| Jun 30, 2023 | 1,549.00 |
| Mar 31, 2023 | 1,330.00 |
| Dec 31, 2022 | 458.00 |
| Sep 30, 2022 | 1,227.00 |
| Jun 30, 2022 | 901.00 |
| Mar 31, 2022 | 397.00 |
| Dec 31, 2021 | -9,121.00 |
| Sep 30, 2021 | -3,983.00 |